Products
2660 products
Code | Description | Unit |
---|---|---|
EPY0000709 | Oxitropium bromide | EP unit |
EPY0000711 | Somatropin/desamidosomatropin resolution mixture | EP unit |
EPY0000712 | Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP | EP unit |
EPY0000713 | Oxitropium bromide impurity D - (1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine) | EP unit |
EPY0000714 | Ritonavir | EP unit |
EPY0000715 | Oxitropium bromide impurity B - (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine) | EP unit |
EPY0000716 | Testosterone isocaproate for system suitability | EP unit |
EPY0000717 | Moxifloxacin for peak identification | EP unit |
EPY0000718 | Lorazepam impurity D - (5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H- 1,4-benzodiazepine-2,3-dione | EP unit |
EPY0000719 | Paclitaxel semi-synthetic for peak identification | EP unit |
EPY0000720 | Triglycerol diisostearate | EP unit |
EPY0000721 | Mirtazapine for system suitability | EP unit |
EPY0000724 | Norgestimate | EP unit |
EPY0000725 | Norgestimate for system suitability | EP unit |
EPY0000726 | Dorzolamide hydrochloride | EP unit |
EPY0000727 | Dorzolamide impurity A - (4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b] thiopyran-2-sulphonamide 7,7-dioxide | EP unit |
EPY0000731 | Felbinac | EP unit |
EPY0000732 | Felbinac impurity A - 4-acetyl biphenyl | EP unit |
EPY0000733 | Dacarbazine | EP unit |
EPY0000734 | Dacarbazine impurity A - 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2-azahypoxanthine) | EP unit |
EPY0000735 | Dacarbazine impurity B - 5-amino-1H-imidazole-carboxamide | EP unit |
EPY0000736 | Flavoxate hydrochloride | EP unit |
EPY0000737 | Flavoxate impurity A - 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid | EP unit |
EPY0000738 | Flavoxate impurity B - ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate | EP unit |
EPY0000739 | Paclitaxel semi-synthetic for system suitability | EP unit |
EPY0000740 | Adrenaline impurity mixture | EP unit |
EPY0000742 | Ropivacaine hydrochloride monohydrate | EP unit |
EPY0000743 | Ropivacaine impurity G - (+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)-ropivacaine) | EP unit |
EPY0000744 | Dextranomer | EP unit |
EPY0000745 | Macrogol 40 sorbitol heptaoleate | EP unit |
EPY0000746 | Indinavir for system suitability | EP unit |
EPY0000747 | Moxidectin for system suitability | EP unit |
EPY0000748 | Tibolone - Reference Spectrum | EP unit |
EPY0000749 | Essential oil | EP unit |
EPY0000750 | Dorzolamide for system suitability | EP unit |
EPY0000751 | Fexofenadine impurity A - 2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl] butanoyl]phenyl]-2-methylpropanoic acid | EP unit |
EPY0000752 | Fexofenadine impurity B - 2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid | EP unit |
EPY0000753 | Fexofenadine impurity C - (1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)phenyl]butan-1-ol | EP unit |
EPY0000754 | Methenamine | EP unit |
EPY0000755 | Nonoxinol 9 | EP unit |
EPY0000756 | Fenoterol for peak identification | EP unit |
EPY0000757 | Riboflavin for peak identification | EP unit |
EPY0000758 | Clozapine for peak identification | EP unit |
EPY0000759 | Trimipramine for peak identification | EP unit |
EPY0000760 | Vinpocetine impurity D - (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (dihydrovinpocetine) | EP unit |
EPY0000762 | Fluorouracil impurity A - pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) | EP unit |
EPY0000763 | Fluorouracil impurity B - dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil) | EP unit |
EPY0000764 | Fluorouracil impurity C - pyrimidine-2,4(1H,3H)-dione (uracil) | EP unit |
EPY0000765 | Fluorouracil impurity F - 2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil) | EP unit |
EPY0000766 | Phthalic acid benzene-1,2-dicarboxylic acid | EP unit |
EPY0000767 | Resorcinol benzene-1,3-diol | EP unit |
EPY0000768 | Etodolac for peak identification | EP unit |
EPY0000769 | Promethazine impurity D - (2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide | EP unit |
EPY0000770 | Methacrylic acid-ethylacrylate copolymer (1:1) type A | EP unit |
EPY0000771 | Perindopril for peak identification | EP unit |
EPY0000772 | Moxidectin | EP unit |
EPY0000773 | Lansoprazole | EP unit |
EPY0000774 | Lansoprazole for peak identification | EP unit |
EPY0000775 | Benzbromarone | EP unit |
EPY0000776 | Methylergometrine maleate | EP unit |
EPY0000777 | Methylergometrine maleate for system suitability | EP unit |
EPY0000778 | Warfarin sodium clathrate | EP unit |
EPY0000779 | Chlortalidone for peak identification | EP unit |
EPY0000780 | Paraffin (hard) | EP unit |
EPY0000782 | Fosfomycin calcium | EP unit |
EPY0000784 | Cellulose acetate | EP unit |
EPY0000786 | Rosmarinic acid | EP unit |
EPY0000787 | Caffeine for system suitability | EP unit |
EPY0000788 | Indinavir | EP unit |
EPY0000789 | Fexofenadine hydrochloride | EP unit |
EPY0000790 | Vinpocetine impurity C - ethyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (methoxyvinpocetine) | EP unit |
EPY0000791 | Fluorouracil impurity mixture | EP unit |
EPY0000792 | Poly(vinyl acetate) dispersion 30% | EP unit |
EPY0000793 | Vinyl acetate | EP unit |
EPY0000794 | Glycerol monocaprylate | EP unit |
EPY0000795 | Glycerol monocaprylocaprate | EP unit |
EPY0000796 | Fluorescein | EP unit |
EPY0000797 | Promethazine for peak identification | EP unit |
EPY0000799 | Tributyl acetylcitrate for peak identification | EP unit |
EPY0000800 | Ascorbyl palmitate | EP unit |
EPY0000801 | Clonidine impurity B - 1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole | EP unit |
EPY0000802 | Dipyridamole for peak identification | EP unit |
EPY0000803 | Ethambutol for system suitability | EP unit |
EPY0000804 | Fluorescein impurity C - 2-(2,4-dihydroxybenzoyl)benzoic acid | EP unit |
EPY0000805 | Oleuropein | EP unit |
EPY0000806 | Arbutin | EP unit |
EPY0000807 | Desflurane impurity A - 1,1'-oxybis(1,2,2,2-tetrafluoroethane) | EP unit |
EPY0000808 | Sodium phenylbutyrate | EP unit |
EPY0000809 | Sodium phenylbutyrate impurity C - 4-cyclohexylbutanoic acid | EP unit |
EPY0000810 | Acemetacin | EP unit |
EPY0000811 | Acemetacin impurity A - 4-chlorobenzoic acid | EP unit |
EPY0000812 | Bisoprolol fumarate | EP unit |
EPY0000813 | Bisoprolol for system suitability (Bisoprolol hemifumarate salt) | EP unit |
EPY0000814 | Selamectin | EP unit |
EPY0000815 | Selamectin for system suitability | EP unit |
EPY0000816 | Atropine impurity B - (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate (noratropine) | EP unit |
EPY0000818 | Clotrimazole impurity E - (2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) | EP unit |
EPY0000819 | Marbofloxacin | EP unit |
EPY0000820 | Marbofloxacin for peak identification | EP unit |
EPY0000821 | Molsidomine | EP unit |